Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

Skip to main content

Table 1 Demographic data of study participants

From: The preparedness and knowledge of pharmacists and general practitioners in managing human monkeypox: a highly spreading infectious disease

Variables

Community pharmacists

Clinical pharmacists

General practitioners

P-value

Gender

 Male

106 (39.0%)

89 (40.1%)

103 (47.7%)

0.051

 Female

166 (61.0%)

133 (59.9%)

113 (52.3%)

Age

 Range

21–57

21–55

23–49

0.0001

 Mean ± SD

26.15 ± 5.54

28.60 ± 6.73

27.12 ± 4.89

Residence

    

 Upper Egypt

97 (35.7%)

89 (40.0%)

86 (39.8%)

0.773

 Center

92 (33.8%)

69 (31.0%)

63 (29.2%)

 Delta

83 (30.5%)

64 (29.0%)

67 (31.0%)

Recent medical education on hMPV

 Yes

54 (20.0%)

51 (23.0%)

52 (24.1%)

0.659

 No

218 (80.0%)

171 (77.0%)

164 (75.9%)

Egypt reported positive cases

 Yes

111 (40.8%)

107 (48.2%)

109 (50.5%)

0.045

 No

49 (18.0%)

29 (13.1%)

20 (9.3%)

 I do not know

112 (41.2%)

86 (38.7%)

87 (39.2%)

Positive cases in nearby countries

 Yes

115 (42.3%)

111 (50.0%)

120 (55.6%)

0.061

 No

25 (9.2%)

16 (7.2%)

13 (6.0%)

 I do not know

132 (48.5%)

95 (42.8%)

83 (38.4%)

Total knowledge scores

    

 Range

4–23

5–24

4–23

0.793

 Mean ± SD

12.67 ± 3.48

12.86 ± 3.22

12.68 ± 3.20

  1. Statistically significant (p < 0.05)
  2. Data are reported as numbers (Percentages) and mean ± standard deviation (SD)